CYN vs. INMB

Last updated Jun 3, 2026

CYN (CYNGN Inc.) and INMB (INmune Bio, Inc.) are both stocks. CYN operates in Software - Application (Technology), while INMB operates in Biotechnology (Healthcare). Over the past 3 years, CYN returned -95.21%/yr vs -43.47%/yr for INMB. At a 0.17 correlation, their price movements are largely independent.

Performance

CYN vs. INMB - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in CYNGN Inc. (CYN) and INmune Bio, Inc. (INMB). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, CYN achieves a -39.50% return, which is significantly lower than INMB's -8.97% return.

CYN

• 1D: -2.04%
• 1M: -14.29%
• YTD: -39.50%
• 6M: -57.14%
• 1Y: -70.61%
• 3Y*: -95.21%
• 5Y*: —
• 10Y*: —

INMB

• 1D: 2.16%
• 1M: -5.96%
• YTD: -8.97%
• 6M: -9.55%
• 1Y: -80.25%
• 3Y*: -43.47%
• 5Y*: -36.14%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

CYN vs. INMB - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
CYN CYNGN Inc.	-39.50%	-98.13%	-94.13%	-76.37%	-85.03%	-39.19%
INMB INmune Bio, Inc.	-8.97%	-66.60%	-58.53%	77.60%	-37.84%	-45.74%

Correlation

The correlation between CYN and INMB is 0.24, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.24
Correlation (3Y) Calculated over the trailing 3-year period	0.23
Correlation (All Time) Calculated using the full available price history since Oct 21, 2021	0.17

Fundamentals

Market Cap CYN : $15.85M INMB : $37.75M
EPS CYN : -$4.23 INMB : -$1.61
PB Ratio CYN : 0.31 INMB : 1.92
Total Revenue (TTM) CYN : $276.40K INMB : $0.00
Gross Profit (TTM) CYN : $95.11K INMB : -$108.00K
EBITDA (TTM) CYN : -$25.99M INMB : -$26.72M

Return for Risk

CYN vs. INMB — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CYN

CYN Risk / Return Rank: 23
CYN Sharpe Ratio Rank: 25
CYN Sortino Ratio Rank: 29
CYN Omega Ratio Rank: 29
CYN Calmar Ratio Rank: 11
CYN Martin Ratio Rank: 22

INMB

INMB Risk / Return Rank: 9
INMB Sharpe Ratio Rank: 9
INMB Sortino Ratio Rank: 8
INMB Omega Ratio Rank: 7
INMB Calmar Ratio Rank: 4
INMB Martin Ratio Rank: 18

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CYN vs. INMB - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for CYNGN Inc. (CYN) and INmune Bio, Inc. (INMB). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	CYN	INMB	Difference
Sharpe ratio Return per unit of total volatility	-0.36	-0.80	+0.44
Sortino ratio Return per unit of downside risk	-0.05	-1.24	+1.19
Omega ratio Gain probability vs. loss probability	1.00	0.83	+0.17
Calmar ratio Return relative to maximum drawdown	-0.77	-0.94	+0.17
Martin ratio Return relative to average drawdown	-0.95	-1.07	+0.12
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

CYN vs. INMB - Sharpe Ratio Comparison

The current CYN Sharpe Ratio is -0.36, which is higher than the INMB Sharpe Ratio of -0.80. The chart below compares the historical Sharpe Ratios of CYN and INMB, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	CYN	INMB	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.36	-0.80	+0.44
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	-0.42	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.46	-0.23	-0.23

Drawdowns

CYN vs. INMB - Drawdown Comparison

The maximum CYN drawdown since its inception was -100.00%, roughly equal to the maximum INMB drawdown of -95.98%. Use the drawdown chart below to compare losses from any high point for CYN and INMB.

Drawdown Indicators

	CYN	INMB	Difference
Max Drawdown Largest peak-to-trough decline	-100.00%	-95.98%	-4.02%
Max Drawdown (1Y) Largest decline over 1 year	-91.73%	-86.16%	-5.57%
Max Drawdown (3Y) Largest decline over 3 years	-99.99%	-92.01%	-7.98%
Max Drawdown (5Y) Largest decline over 5 years	—	-95.98%	—
Current Drawdown Current decline from peak	-100.00%	-94.90%	-5.10%
Average Drawdown Average peak-to-trough decline	-90.60%	-60.46%	-30.14%
Ulcer Index Depth and duration of drawdowns from previous peaks	74.48%	75.51%	-1.03%

Volatility

CYN vs. INMB - Volatility Comparison

The current volatility for CYNGN Inc. (CYN) is 19.19%, while INmune Bio, Inc. (INMB) has a volatility of 21.76%. This indicates that CYN experiences smaller price fluctuations and is considered to be less risky than INMB based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	CYN	INMB	Difference
Volatility (1M) Calculated over the trailing 1-month period	19.19%	21.76%	-2.57%
Volatility (6M) Calculated over the trailing 6-month period	70.31%	53.04%	+17.27%
Volatility (1Y) Calculated over the trailing 1-year period	197.58%	100.36%	+97.22%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	198.47%	85.95%	+112.52%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	198.47%	92.82%	+105.65%

Dividends

CYN vs. INMB - Dividend Comparison

Neither CYN nor INMB has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both CYN and INMB in my portfolio?

CYN and INMB have a correlation of 0.24, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, CYN or INMB?

INMB has higher volatility (21.76%) compared to CYN (19.19%). In terms of maximum drawdown, CYN dropped -100.00% vs INMB's -95.98%.

Which has better risk-adjusted returns?

CYN currently has the higher Sharpe Ratio (-0.36 vs -0.80), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.